Company / Net Income
CG Oncology, Inc. Net Income History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$161.0M
FY2025
5-year range
-$161.0M / -$48.6M
FY2023-FY2025
Trend
-82.9%
vs FY2024
Sector context
#137 of 216
Health Care
What the data says
At -$161M, CG Oncology, Inc.'s net income ranks #137 of 216 in the Health Care sector. Declined from -$49M to -$161M over the past 2 years.
Based on SEC 10-K filings.
-$161M in FY2025.
Declined from -$49M to -$161M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#137 of 216 in Health CareTop 63% of 216This company -$161.0M Sector average $454.3M
▼
-135.4% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 82.9% year-over-year.
- Ranks #137 out of 216 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$161.0M | -82.9% |
| FY2024 | -$88.0M | -81.1% |
| FY2023 | -$48.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026